Acta Med. 2003, 46: 183-188
https://doi.org/10.14712/18059694.2019.31
Platelets Activation in Patients Undergoing PTCA and Their Responsiveness After in vitro Stimulation
References
1. CH, Ellison N, Budzynski AZ et al. Direct detection of activated platelets and platelet – derived microparticles in humans. Blood 1990; 75(1): 128–38.
2. CH, Shattil SJ. Immunological detection of activated platelets in clinical disorders. Thromb Haemostas 1991; 65(5):467–73.
3. KA, Mitchell J. Analysis of platelets by flow cytometry. Methods in Cell Biology 1994; 42:275–94.
<https://doi.org/10.1016/S0091-679X(08)61080-8>
4. KA, Rinder HM, Mitchell JG et al. Correlated measurement of platelet release and aggregation in whole blood. Cytometry 1989; 10:448–55.
<https://doi.org/10.1002/cyto.990100413>
5. M, Prisco D, Antonucci E et al. The pre-procedural platelet state predicts clinical recurrence after coronary angioplasty. Int J Clin Lab Res 1999; 29(4):145–9.
<https://doi.org/10.1007/s005990050081>
6. GJ, Nichols TC, Bode AP et al. Assessment of platelet activation by coronary sinus blood sampling during baloon angioplasty and directional coronary atherectomy. Am J Cardiol 1997; 80(7):871–7.
<https://doi.org/10.1016/S0002-9149(97)00538-9>
7. MI, Benoit MR, Barnard RM. Increased platelet reactivity and circulating monocyte-platelet aggregates in patient with stable coronary artery disease. J Am Coll Cardiol 1998; 31(2):352–8.
<https://doi.org/10.1016/S0735-1097(97)00510-X>
8. CM, Gonias SL, Gimple LW et al. Platelet activation during coronary angioplasty in humans. Circulation 1993; 88:2728–33.
<https://doi.org/10.1161/01.CIR.88.6.2728>
9. MP, Mujais SK, Schmidt B et al. Platelet leukocyte aggregation during hemodialysis. Kidney Int 1994; 46:489–95.
<https://doi.org/10.1038/ki.1994.299>
10. M, Neumann FJ, Ott I et al. Platelet function in acute myocardial infarction treated with direct angioplasty. Circulation 1996; 93:229–37.
<https://doi.org/10.1161/01.CIR.93.2.229>
11. M, Neumann FJ, Ott I et al. Role of activation-dependent platelet membrane glycoproteins in development of subacute occlusive coronary stent thrombosis. Coron Artery Dis 1997; 8(3–4):121–8.
<https://doi.org/10.1097/00019501-199703000-00001>
12. K, Kružík P, Mikolajová M et al. The fluorescence flow cytometry technique in the diagnosis of hereditary platelet disorders—a case of Glanzmann’s thrombasthenia. Cas Lek Cesk 1994; 133(23):734–6.
13. T, Sohma R, Miyazaki T et al. Comparison of activation process of platelets and neutrophils after coronary stent implantation versus balloon angioplasty for stable angina pectoris. Am J Cardiol 2000; 86(10):1057–62.
<https://doi.org/10.1016/S0002-9149(00)01159-0>
14. T, Nakai K, Ono M et al. Can the risk for acute cardiac events in acute coronary syndrome be indicated by platelet membrane activation marker P-selectin? Coron Artery Dis 1995, 6(8):645–50.
<https://doi.org/10.1097/00019501-199508000-00009>
15. P, Pajor L. Advantages of CD45 vs. side scatter based gating in the course of flow cytometric immuno-phenotyping in malignant hematologic diseases. Orv Hetil 1998; 139(42):2509–13.
16. CHJ, Panesar M, Wilson DJ et al. Different effects of calcium antagonists, nitrates and β-blockers on platelet function. Possible importance for the treatment of unstable angina. Circulation 1997; 95:125–32.
<https://doi.org/10.1161/01.CIR.95.1.125>
17. Koksch M. Durchflusszytometrische Diagnostik von Thrombozyten. Coulter – Immunotech Diagnostics. Manual. Leipzig.1997:18–26.
18. P, Tschoepe D, Nieuwenhuis HK et al. PTCA: periprocedural platelet activation. Part II of Duesseldorf PTCA platelet study (DPPS). Eur Heart J 1996; 17(8):1216–22.
<https://doi.org/10.1093/oxfordjournals.eurheartj.a015039>
19. JM, Shankey TV, Walenga JM et al. Flow cytometric evaluation of platelet activation by ionic or nonionic contrast media and modulation by heparin and recombinant hirudin. Invest Radiol 1995; 30(2):90–7.
<https://doi.org/10.1097/00004424-199502000-00005>
20. J, Plow E, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 1995; 333(23):1553–9.
<https://doi.org/10.1056/NEJM199506083322306>
21. N, Goodall AH, Hjemdahl P. A sensitive flow cytometric assay for circulating platelet-leukocyte aggregates. Br J Haematol 1997; 99(4):808–16.
<https://doi.org/10.1046/j.1365-2141.1997.4993305.x>
22. N, Goodall A, Hjemdahl P. Efficient flow cytometric assay for platelet – leukocyte aggregates in whole blood using fluorescence signal triggering. Cytometry 1999; 35:154–61.
<https://doi.org/10.1002/(SICI)1097-0320(19990201)35:2<154::AID-CYTO7>3.0.CO;2-Y>
23. AC, Berchner D, Kuhnel G et al. Relative and absolute changes of activated platelets, microparticles anded platelets, microparticles andation in vitro. Haemostasis 1999; 28(6):277–88.
24. AC, Kühnel G, Kemkes-Matthes B et al. Quantitative assessment of platelets, platelet microparticles, and platelet aggregates with flow cytometry. J Clin Med 1998; 131(6):507–17.
25. AD, Barnard MR, Krueger LA et al. Evaluation of platelet function by flow cytometry. Methods 2000; 21(3):259–70.
<https://doi.org/10.1006/meth.2000.1006>
26. AD, Furman MI. Laboratory markers of platelet activation and their clinical significance. Curr Opin Haematol 1999, 6(5):342–48.
<https://doi.org/10.1097/00062752-199909000-00012>
27. T, Komiyama Y, Masuda M et al. Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery disease. Eur J Clin Invest 1996; 26: 996–1003.
<https://doi.org/10.1046/j.1365-2362.1996.2360585.x>
28. FJ, Ott I, Gawaz M et al. Neutrophil and platelet activation at balooninjured coronary artery plaque in patients undergiong angioplasty. J Am Coll Cardiol 1996; 27(4):819–24.
<https://doi.org/10.1016/0735-1097(95)00563-3>
29. RE, Tomer A., Marzec UM et al. Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection. Arterioscler Thromb 1992; 12:1475–81.
<https://doi.org/10.1161/01.ATV.12.12.1475>
30. J, Holada K, Janota J et al. Surface expression of major membrane glycoproteins on resting and TRAP- activated neonatal platelets. Ped Res 1999; 46(4):445–49.
<https://doi.org/10.1203/00006450-199910000-00014>
31. A, Rothe G, Lodes H et al. Effects of extracorporeal circulation and heparin on the phenotype of platelet surface antigens folowing heart surgery. Thromb Res 2000; 97:379–86.
<https://doi.org/10.1016/S0049-3848(99)00181-4>
32. E, Wozniak, J, Dzieciatkowska A et al. In comparison to progenitor platelets, microparticles are deficient in GP Ib, GP Ib-derived carbohydrates, glycerophospholipids, glycosphingolipids, and ceramides. Acta Biochim Pol 1998; 45(2):417–28.
33. L, Bath P, Heptinstall S. Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro. Br J Pharmacol 2001; 134(2):353–8.
<https://doi.org/10.1038/sj.bjp.0704248>
<PubMed>
